PPD is a contract research organization that provides comprehensive, integrated drug development, laboratory and lifecycle management services to pharmaceutical, biotechnology, medical device, academic and government organizations.

Accelerated Enrollment Solutions

Evidera

PPD Biotech Solutions

PPD Laboratory Services

PPD is part of Thermo Fisher Scientific, the world leader in serving science. Together, Thermo Fisher and its PPD clinical research business are creating a unique opportunity to advance their shared pursuit to enable customers to make the world healthier by accelerating the development of new medicines. We offer a comprehensive suite of world-class services across the clinical development spectrum – from scientific discovery, to assessing safety, efficacy, and health care outcomes, to managing clinical trial logistics, to the development and manufacturing of the drug product. 

Science 37

🗳️ Last week to vote! » https://bit.ly/46V4v5I

We're honored to be considered for the Society for Clinical Research Sites (SCRS) Eagle Award, which recognizes outstanding leadership, professionalism, integrity, passion and dedication to advancing the clinical research profession through strong site partnerships.

We're grateful for the collaborative relationships with our site partners, and if you feel we have met these exceptional standards, we would be humbled to receive your vote for best CRO.

Our colleagues are enjoying connecting and sharing insights at #AAIC24 in Philadelphia. Let's unlock the future of memory care together. Find our team at booth 920!

📢 #AAIC24: Meet our Alzheimer's clinical research specialists at booth 920 this week in Philadelphia!

Our #pediatric experts are dedicated to maximizing efficiency, ensuring patient safety and achieving your study goals. With customized strategies tailored specifically for pediatric research, we strive to provide a seamless and successful trial experience. Our team is equipped with subject matter expertise and operational capabilities to help your pediatric #clinicaltrials meet study timelines.

Discover how we can help you reach your objectives. » https://bit.ly/3LPDSFL

In early #clinicaldevelopment, transparency around the research question of interest – the #estimand – is key. An estimand is a precise description of the treatment effect to be summarized in your research. From this white paper you'll learn why they're relevant in #clinicalpharmacology trials, key steps in the estimand thinking process, how they aid in clarifying R&D goals, and their growing use in #clinicaltrial protocols following new #regulatoryguidance. » https://bit.ly/3A6yJqd

For years, clinical trials have not accurately reflected the diversity within our population, leading to inequities in healthcare and scientific research. Yesterday, we hosted a Congressional briefing with industry leaders and patient advocates dedicated to bridging the gap for a more equitable future in science.  
 
Thank you to our panelists: Thermo Fisher Scientific’s Dr. Rose Blackburne, MD, MBA, Vice President, Medical Science and Strategy, and Global Head of General Medicine and Women’s Health, Vanderbilt University Medical Center’s Dr. Sheila Kusnoor, National Minority Quality Forum’s Dr. Salvatore (Salvo) Alesci and Cystic Fibrosis Foundation’s Ashleigh Tharp. Cross-industry collaboration is essential to support scientific discovery and understand how we can better connect communities to ongoing research and treatment discovery.

COM:PPD

PPD

Financials Not Available